HIKMA PHARMACEUTICALS USA H-1B Visa Sponsorship & Salary Data

The median H-1B salary at HIKMA PHARMACEUTICALS USA is $104,562, based on 124 certified filings from FY 2020 to FY 2026. This is 13% lower than the national H-1B median salary of $120,000. Compensation at HIKMA PHARMACEUTICALS USA reflects their market positioning, with entry-level roles starting around $90,834 and senior positions reaching $135,479 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at HIKMA PHARMACEUTICALS USA range from $74,859 at the 10th percentile to $135,479 at the 90th percentile, showing a $60,620 spread across experience levels and roles. The 25th percentile is $90,834 and the 75th percentile is $120,000.

Yes, HIKMA PHARMACEUTICALS USA actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 136 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 124 certified applications and a 0% denial rate, HIKMA PHARMACEUTICALS USA maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), HIKMA PHARMACEUTICALS USA filed 5 H-1B applications, with 4 certified and 0 denied. Over 7 years of data, HIKMA PHARMACEUTICALS USA has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

HIKMA PHARMACEUTICALS USA's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 136 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating HIKMA PHARMACEUTICALS USA as a potential H-1B sponsor.

This is an excellent approval rate, indicating HIKMA PHARMACEUTICALS USA has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

HIKMA PHARMACEUTICALS USA sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 124 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles HIKMA PHARMACEUTICALS USA most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at HIKMA PHARMACEUTICALS USA:

The most frequently sponsored role is Research Scientist with 13 filings at a median salary of $91,000. This is followed by Research Scientist III (13 filings) and Principal Research Scientist.

HIKMA PHARMACEUTICALS USA's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where HIKMA PHARMACEUTICALS USA sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top HIKMA PHARMACEUTICALS USA H-1B locations:

The largest H-1B hub for HIKMA PHARMACEUTICALS USA is Columbus, OH with 63 filings at a median salary of $100,000. The highest-paying location is Eatontown, NJ at $160,555 median. Salaries range from $90,834 to $160,555 across office locations.

HIKMA PHARMACEUTICALS USA's median H-1B salary has changed by -6% from FY 2020 ($110,000) to FY 2026 ($103,126). Tracking salary trends over time reveals how HIKMA PHARMACEUTICALS USA adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at HIKMA PHARMACEUTICALS USA.

Year-by-year breakdown:

• FY 2022: $97,513 (18 certified)
• FY 2023: $104,562 (14 certified)
• FY 2024: $113,526 (20 certified)
• FY 2025: $111,925 (14 certified)
• FY 2026: $103,126 (4 certified)

Salary levels have remained relatively stable at HIKMA PHARMACEUTICALS USA.

HIKMA PHARMACEUTICALS USA primarily files H-1B applications at Wage Level IV, accounting for 41% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making HIKMA PHARMACEUTICALS USA's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 90% of positions at Level II or higher, HIKMA PHARMACEUTICALS USA typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

HIKMA PHARMACEUTICALS USA's median H-1B salary of $104,562 is 13% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating HIKMA PHARMACEUTICALS USA's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare HIKMA PHARMACEUTICALS USA's offerings with similar companies in your field for a more accurate assessment.

HIKMA PHARMACEUTICALS USA's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. HIKMA PHARMACEUTICALS USA's higher proportion of Level III-IV positions (65%) may benefit from wage-based lottery prioritization.

With 124 certified filings, HIKMA PHARMACEUTICALS USA invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.